56 aziende

AziendaUltimo prezzoRitorno 7DRitorno a 1 annoCap. di mercatoObiettivo degli analistiValutazioneCrescitaRendimento del dividendoIndustria
6919
NT$103.00-5.5%-45.9%NT$164.9bNT$240.005450.5136.5%n/aPharmaceuticals & Biotech
6472
NT$439.50-1.3%-40.0%NT$56.0bNT$579.0430.846.0%2.3%Pharmaceuticals & Biotech
4105
NT$78.10-1.1%1.4%NT$19.4bNT$92.0011.2n/a5.8%Pharmaceuticals & Biotech
1789
NT$19.05-2.1%5.2%NT$15.1bn/a399.3n/a1.5%Pharmaceuticals & Biotech
3705
NT$56.000.5%-0.2%NT$14.9bn/a16.6n/a5.4%Pharmaceuticals & Biotech
6620
NT$76.701.2%-6.8%NT$12.6bNT$83.0026.118.7%2.6%Pharmaceuticals & Biotech
1720
NT$56.60-0.9%10.0%NT$10.1bn/a9.8n/a3.2%Pharmaceuticals & Biotech
6550
NT$11.351.8%-71.9%NT$9.8bn/a140.9n/an/aPharmaceuticals & Biotech
4162
NT$60.502.0%-11.0%NT$8.7bn/a16.1n/a3.3%Pharmaceuticals & Biotech
4142
NT$17.95-0.8%-3.8%NT$7.6bn/a5.5n/a0%Pharmaceuticals & Biotech
6976
NT$12.151.3%-21.6%NT$7.4bn/a1.4n/an/aPharmaceuticals & Biotech
4167
Nuovo
NT$20.15-2.7%13.9%NT$6.7bn/a6.5n/a3.7%Pharmaceuticals & Biotech
1734
NT$30.800.5%5.6%NT$6.6bn/a17.7n/a3.1%Pharmaceuticals & Biotech
4746
NT$49.65-7.9%-27.4%NT$5.9bn/a12.6n/a6.0%Pharmaceuticals & Biotech
4166
NT$24.702.7%0%NT$5.5bn/a23.4n/an/aPharmaceuticals & Biotech
3176
NT$38.107.2%26.6%NT$5.3bn/a4.2n/an/aPharmaceuticals & Biotech
3716
NT$35.15-2.5%3.4%NT$5.1bn/a13.6n/a2.9%Pharmaceuticals & Biotech
4726
NT$24.20-2.2%-35.6%NT$5.0bn/a6.1n/an/aPharmaceuticals & Biotech
1760
Nuovo
NT$58.60-0.3%-17.6%NT$5.0bn/a23.4n/a3.4%Pharmaceuticals & Biotech
6875
NT$33.001.2%-33.7%NT$4.3bn/a79.9n/an/aPharmaceuticals & Biotech
4120
NT$47.700.8%-5.4%NT$4.1bn/a0.9n/a8.4%Pharmaceuticals & Biotech
4178
NT$17.500.3%-30.6%NT$3.8bn/a10.6-6.2%n/aPharmaceuticals & Biotech
1799
NT$30.050.2%-34.5%NT$3.7bn/a4.7n/an/aPharmaceuticals & Biotech
1783
NT$40.700.5%-7.5%NT$3.6bn/a12.5n/a4.9%Pharmaceuticals & Biotech
Page 1 of 2